The term GLP-3 is not correct
But retatrutide is investigational and won't be available until 20272028, while tirzepatide is FDA-approved and available by prescription today
On average, GLP-1 medications can lead to a weight loss of around 2-4 kilograms, or about 4.4-8.8 pounds, over 6 months to a year
[DOI] [PMC free article] [PubMed] [Google Scholar] 70.Koska J, Sands M, Burciu C, DSouza KM, Raravikar K, Liu I, Truran S, Franco DA, Schwartz EA, Schwenke DC, DAlessio D, Migrino RQ, Reaven PD
This is particularly important for investigational medicines, as it helps build the safety evidence base
Swimming Pools Without Maintenance Having stagnant water in dirty pools will invite mosquitoes that look for a water source